Vaccine News and Research

Latest Vaccine News and Research

Concomitant tuberculosis disease significantly impacts HIV immune responses in people with HIV

Concomitant tuberculosis disease significantly impacts HIV immune responses in people with HIV

UCF researcher develops a new, more precise treatment for acute respiratory viral infections

UCF researcher develops a new, more precise treatment for acute respiratory viral infections

Spikevax approved for use in children aged 6 months to 5 years

Spikevax approved for use in children aged 6 months to 5 years

Game-changers reshaping our world: From mRNA vaccines to AI-powered medicine

Game-changers reshaping our world: From mRNA vaccines to AI-powered medicine

PETA announces $50,000 grant to explore the reasons for HIV vaccine research failures

PETA announces $50,000 grant to explore the reasons for HIV vaccine research failures

Waco COVID Survey provides insights into the dynamics of COVID-19 transmission, health behaviors

Waco COVID Survey provides insights into the dynamics of COVID-19 transmission, health behaviors

Study reveals how immune system protects the body against pathogens

Study reveals how immune system protects the body against pathogens

SARS-CoV-2 infection leads to higher IgA levels in breast milk than vaccination

SARS-CoV-2 infection leads to higher IgA levels in breast milk than vaccination

Novel Rutgers vaccine may provide more durable protection against SARS-CoV-2

Novel Rutgers vaccine may provide more durable protection against SARS-CoV-2

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Is there a risk of menstrual disturbance and bleeding after SARS-CoV-2 vaccination in pre-and post-menopausal females?

Is there a risk of menstrual disturbance and bleeding after SARS-CoV-2 vaccination in pre-and post-menopausal females?

Omicron's grip on Sweden: High transmission rates persist despite high seroprevalence

Omicron's grip on Sweden: High transmission rates persist despite high seroprevalence

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

People encouraged to get first and second dose of Covid vaccine before offer ends

People encouraged to get first and second dose of Covid vaccine before offer ends

Did race/ethnicity disparities in severe COVID-19 outcomes persist in the era of vaccination?

Did race/ethnicity disparities in severe COVID-19 outcomes persist in the era of vaccination?

Evaluating the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines

Evaluating the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines

Study: No evidence of increased risk of menstrual changes after covid-19 vaccination

Study: No evidence of increased risk of menstrual changes after covid-19 vaccination

Study finds COVID-19 vaccine effectiveness against Omicron rapidly wanes over time

Study finds COVID-19 vaccine effectiveness against Omicron rapidly wanes over time

Millions struggle: The hidden impact of post-COVID conditions on US adults

Millions struggle: The hidden impact of post-COVID conditions on US adults

Study provides the most comprehensive characterization of global COVID-19 variant transitions

Study provides the most comprehensive characterization of global COVID-19 variant transitions

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.